Treatments utilizing Clustered Regularly Interspace Short Palindromic Repeats (CRISPR), continue to rack up clinical success. The latest research on blood…
McAlinden Research PartnersJune 16, 2020
China is ramping up its manufacturing of medical goods, including masks, PPE, and ventilators, as it seeks to ship them…
McAlinden Research PartnersApril 28, 2020
All sizes of pharmaceutical firms from giants like Johnson & Johnson to young guns like Moderna, yet to bring their…
McAlinden Research PartnersApril 1, 2020
Coronavirus could be the game changer that propels telemedicine into the mainstream. Virtual clinical services have been around since the…
McAlinden Research PartnersMarch 16, 2020
The FDA and a number of major pharmaceutical firms have warned of drug shortages resulting from chemical plant shut downs…
McAlinden Research PartnersMarch 3, 2020
The coronavirus outbreak aka 2019-nCoV is having an outsize impact on some industries and their share prices. Airline, energy, and…
McAlinden Research PartnersFebruary 3, 2020
A virus called 2019-nCoV that emerged last month in Central China is spreading so fast that it risks becoming a…
McAlinden Research PartnersJanuary 23, 2020
New research on CRISPR techniques that could provide treatments and improved diagnostics for several major viruses and other medical conditions…
McAlinden Research PartnersNovember 13, 2019
New developments in CRISPR gene editing technology have opened the door to potential cures for 89% of known disease-causing genetic…
McAlinden Research PartnersOctober 29, 2019
